A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans <sup>†</sup>
Leishmaniasis, a parasitic disease that represents a threat to the life of millions of people around the globe, is currently lacking effective treatments. We have previously reported on the antileishmanial activity of a series of synthetic 2-phenyl-2,3-dihydrobenzofurans and some qualitative structu...
Main Authors: | Freddy A. Bernal, Thomas J. Schmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/8/3399 |
Similar Items
-
Exploring Synthetic Dihydrobenzofuran and Benzofuran Neolignans as Antiprotozoal Agents against <i>Trypanosoma cruzi</i>
by: Mariana C. Pagotti, et al.
Published: (2023-02-01) -
Cytotoxic Activity of Wild Plant and Callus Extracts of <i>Ageratina pichinchensis</i> and 2,3-Dihydrobenzofuran Isolated from a Callus Culture
by: Mariana Sánchez-Ramos, et al.
Published: (2023-10-01) -
Hierarchical Clustering and Target-Independent QSAR for Antileishmanial Oxazole and Oxadiazole Derivatives
by: Henrique R. Teles, et al.
Published: (2022-08-01) -
Investigating the binding affinity, molecular dynamics, and ADMET properties of 2,3-dihydrobenzofuran derivatives as an inhibitor of fungi, bacteria, and virus protein
by: Ashutosh Nath, et al.
Published: (2021-06-01) -
Synthesis, antileishmanial activity and QSAR studies of 2-chloro- N -arylacetamides
by: Stefânia Neiva Lavorato, et al.
Published: (2017-04-01)